Stryhn A, Pedersen L O, Ortiz-Navarrete V, Buus S
Institute of Medical Microbiology and Immunology, University of Copenhangen, Denmark.
Eur J Immunol. 1994 Jun;24(6):1404-9. doi: 10.1002/eji.1830240625.
A panel of antigen-specific, major histocompatibility complex class I-restricted T cell hybridomas has been generated to examine the capacity of peptide/class I complexes to stimulate T cells at the molecular level. Peptide/class I complexes were generated in detergent solution, purified and quantitated. Latex particles were subsequently coated with known amounts of preformed complexes and used to stimulate the T cell hybridomas. Stimulation was specific, i.e. only the appropriate peptide/class I combination were stimulatory, and quite sensitive, i.e. as little as 300 complexes per bead could be detected by the T cells. Preformed complexes were about 500,000 times more potent than free peptide in terms of T cell stimulation, demonstrating the physiological relevancy of the biochemically generated complexes. Surprisingly, the majority (including the most sensitive of the hybridomas) had lost CD8 expression, suggesting that antigen-specific stimulation of class I-restricted T cell hybridomas, as assessed by IL-2 release, does not depend on CD8.
已产生一组抗原特异性、主要组织相容性复合体 I 类限制的 T 细胞杂交瘤,以在分子水平上检测肽/I 类复合物刺激 T 细胞的能力。肽/I 类复合物在去污剂溶液中产生、纯化并定量。随后用已知量的预先形成的复合物包被乳胶颗粒,并用于刺激 T 细胞杂交瘤。刺激是特异性的,即只有合适的肽/I 类组合具有刺激性,并且相当敏感,即 T 细胞能够检测到每颗珠子低至 300 个复合物。就 T 细胞刺激而言,预先形成的复合物的效力比游离肽强约 500,000 倍,这证明了生化产生的复合物的生理相关性。令人惊讶的是,大多数(包括最敏感的杂交瘤)已经失去了 CD8 表达,这表明通过白细胞介素-2 释放评估的 I 类限制的 T 细胞杂交瘤的抗原特异性刺激不依赖于 CD8。